<p><strong>Pediatric use</strong>: Results of pediatric clinical studies have shown that, on average, the younger the patients, the higher the Recormon doses required. Nevertheless, the recommended dosing schedule should be followed as the individual response cannot be predicted.<br />
<br />
<strong>Geriatric use</strong>: No dedicated studies in geriatric patients were performed. A large proportion of geriatric patients were included in clinical trials with Recormon. A need for special dose adjustments in the geriatric population was not identified.<br />
<br />
<strong>Hepatic Impairment</strong>: No dedicated clinical trials were conducted in patients with hepatic impairment. No special dosage Instructions are available.</p>